Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement

G Mantovani, M Bastepe, D Monk… - Nature Reviews …, 2018 - nature.com
Abstract This Consensus Statement covers recommendations for the diagnosis and
management of patients with pseudohypoparathyroidism (PHP) and related disorders …

Management of hypoparathyroidism: summary statement and guidelines

ML Brandi, JP Bilezikian, D Shoback… - The Journal of …, 2016 - academic.oup.com
Objective: Hypoparathyroidism is a rare disorder characterized by hypocalcemia and absent
or deficient PTH. This report presents a summary of current information about epidemiology …

Hypoparathyroidism

M Mannstadt, JP Bilezikian, RV Thakker… - Nature Reviews …, 2017 - nature.com
Hypoparathyroidism is a disease characterized by inadequately low circulating
concentrations of parathyroid hormone (PTH) resulting in low calcium levels and increased …

Hormonal regulation of biomineralization

A Arnold, E Dennison, CS Kovacs… - Nature Reviews …, 2021 - nature.com
Biomineralization is the process by which organisms produce mineralized tissues. This
crucial process makes possible the rigidity and flexibility that the skeleton needs for …

Diagnosis and management of hypocalcemia

J Pepe, L Colangelo, F Biamonte, C Sonato… - Endocrine, 2020 - Springer
The aim of this clinical narrative review is to summarize and critically appraise the literature
on the differential diagnosis of hypocalcemia and to provide its correct management …

Hypoparathyroidism

RI Gafni, MT Collins - New England Journal of Medicine, 2019 - Mass Medical Soc
Key Clinical Points Hypoparathyroidism Hypoparathyroidism is a rare disease that results in
hypocalcemia. Symptoms, when present, range from paresthesias and muscle cramps to …

Review of hypoparathyroidism

EG Abate, BL Clarke - Frontiers in endocrinology, 2017 - frontiersin.org
Hypoparathyroidism is a rare endocrine disorder in which parathyroid hormone (PTH)
production is abnormally low or absent, resulting in low serum calcium and increased serum …

An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism

I Takacs, E Mezosi, A Soto, P Kamenický… - The Journal of …, 2024 - academic.oup.com
Context Hypoparathyroidism is a rare disorder characterized by a deficiency in PTH
resulting in hypocalcemia, hyperphosphatemia, and hypercalciuria. Eneboparatide is an …

Hypoparathyroidism

JP Bilezikian - The Journal of Clinical Endocrinology & …, 2020 - academic.oup.com
Background Hypoparathyroidism is a rare endocrine disorder characterized by
hypocalcemia and low or undetectable levels of parathyroid hormone. Methods This review …

Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysis

JJ Díez, E Anda, J Sastre, B Pérez Corral… - Endocrine, 2019 - Springer
Purpose The prevalence of postoperative hypoparathyroidism has been studied in registries
and in surgical series with highly variable and imprecise results. However, the frequency of …